Development of antisense therapeutics. Implications for cancer gene therapy.
about
Ribozyme therapy: RNA enzymes to the rescue.Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistanceNew modalities in oncology: antisense oligonucleotides.An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers.Synthesis of 3H-labeled nucleoside-methyl[CT3]phosphonamidite and incorporation into methylphosphonate oligonucleotides for biodistribution and biostability studies.Small antisense RNA to cyclin D1 generated by pre-tRNA splicing inhibits growth of human hepatoma cells.A Phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma.
P2860
Q35144547-FD77204D-B3A8-472A-B6BC-EBE66D46388AQ36254793-1F27CB92-5657-4CE0-94C6-717720F8921EQ39482480-04FF5400-C443-446C-8053-A19C61300A13Q40393595-65D116B4-AB6C-44B8-86F1-461A95AB12C4Q40395758-10003BEA-04D8-4D27-91FE-5AF739B66DE5Q40501377-7C32D084-F6FD-416D-A3D8-B1BC95B75110Q40684788-B2653D7B-EB88-4E69-B2D0-EBD94782EE25
P2860
Development of antisense therapeutics. Implications for cancer gene therapy.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Development of antisense therapeutics. Implications for cancer gene therapy.
@en
type
label
Development of antisense therapeutics. Implications for cancer gene therapy.
@en
prefLabel
Development of antisense therapeutics. Implications for cancer gene therapy.
@en
P2093
P2860
P1476
Development of antisense therapeutics. Implications for cancer gene therapy.
@en
P2093
Froehler BC
Matteucci MD
Milligan JF
P2860
P304
P356
10.1111/J.1749-6632.1994.TB21715.X
P407
P577
1994-05-01T00:00:00Z